Avanos Medical (AVNS) EBT Margin (2013 - 2026)

Avanos Medical has disclosed EBT Margin across 14 years of filings, most recently posting 4.17% for Q1 2026.

• EBT Margin for Q1 2026 came in at 4.17%, down 162.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.54% (up 4779.0% YoY), and the FY2025 annual result was 9.44%, up 4920.0% from the prior year.
• EBT Margin came in at 4.17% for Q1 2026 at Avanos Medical, up from 0.66% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 7.87% in Q4 2022 to a low of 234.13% in Q4 2024.
• The 5-year median for EBT Margin is 3.61% (2024), against an average of 14.16%.
• Across the five-year window, EBT Margin sank 23927 bps in 2024 and soared 23479 bps in 2025, its largest moves.
• Avanos Medical's EBT Margin stood at 7.87% in 2022, then sank by 35 bps to 5.14% in 2023, then sank by 4659 bps to 234.13% in 2024, then surged by 100 bps to 0.66% in 2025, then soared by 529 bps to 4.17% in 2026.
• The last three EBT Margin figures came in at 4.17% (Q1 2026), 0.66% (Q4 2025), and 0.67% (Q3 2025), per Business Quant data.